UBS Call 98 ABL 19.12.2025/ DE000UM6EX33 /
02/08/2024 19:36:51 | Chg.-0.020 | Bid21:56:33 | Ask21:56:33 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.980EUR | -1.00% | - Bid Size: - |
- Ask Size: - |
ABBOTT LABS | 98.00 - | 19/12/2025 | Call |
GlobeNewswire
06/06
Circana’s 2023 New Product Pacesetters Report Reveals Innovation Is Meeting Consumers in New Moments
GlobeNewswire
09/05
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new Pre...
GlobeNewswire
25/03
Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer
GlobeNewswire
15/03
Attention Reckitt Benckiser Group investors: Portnoy Law Firm Announces Investigation into Reckitt B...
GlobeNewswire
14/11/2023
NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports In...
GlobeNewswire
19/10/2023
Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer